BOOM
Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
A yeast fermentate improves gastrointestinal discomfort and constipation by modulation of the gut microbiome: results from a randomized double-blind placebo-controlled pilot trial. ✅
Go to Publication ✅
BMC complementary and alternative medicine (BMC Complement Altern Med ) Vol: 17 Issue 1 Pages: 441 Pub: 2017 Sep 4 Epub: 2017 Sep 4 Authors Pinheiro I , Robinson L , Verhelst A , Marzorati M , Winkens B , den Abbeele PV , Possemiers S , |
|
|
Curated database of commensal, symbiotic and pathogenic microbiota ✅
Generative Bioinformatics (Center of Excellence in Generative Medicine ) Vol: Issue Pages: Pub: 2014 Jun Epub: Authors D'Adamo Peter , |
|
|
Curated database of commensal, symbiotic and pathogenic microbiota ✅
Generative Bioinformatics (Center of Excellence in Generative Medicine ) Vol: Issue Pages: Pub: 2014 Jun Epub: Authors D'Adamo Peter , |
|
|
Impact of probiotic Saccharomyces boulardii on the gut microbiome composition in HIV-treated patients: A double-blind, randomised, placebo-controlled trial. ✅
Go to Publication ✅
PloS one (PLoS One ) Vol: 12 Issue 4 Pages: e0173802 Pub: 2017 Epub: 2017 Apr 7 Authors Villar-García J , Güerri-Fernández R , Moya A , González A , Hernández JJ , Lerma E , Guelar A , Sorli L , Horcajada JP , Artacho A , D Auria G , Knobel H , |
|
|
Effects of probiotics Pediococcus acidilactici strain MA18/5M and Saccharomyces cerevisiae subsp. boulardii strain SB-CNCM I-1079 on fecal and intestinal microbiota of nursing and weanling piglets. ✅
Go to Publication ✅
Journal of animal science (J Anim Sci ) Vol: 93 Issue 11 Pages: 5313-26 Pub: 2015 Nov Epub: Authors Brousseau JP , Talbot G , Beaudoin F , Lauzon K , Roy D , Lessard M , |
|
|
Active dry Saccharomyces cerevisiae can alleviate the effect of subacute ruminal acidosis in lactating dairy cows. ✅
Go to Publication ✅
Journal of dairy science (J Dairy Sci ) Vol: 97 Issue 12 Pages: 7751-63 Pub: 2014 Dec Epub: 2014 Oct 3 Authors AlZahal O , Dionissopoulos L , Laarman AH , Walker N , McBride BW , |
|
|
Active dry Saccharomyces cerevisiae can alleviate the effect of subacute ruminal acidosis in lactating dairy cows. ✅
Go to Publication ✅
Journal of dairy science (J Dairy Sci ) Vol: 97 Issue 12 Pages: 7751-63 Pub: 2014 Dec Epub: 2014 Oct 3 Authors AlZahal O , Dionissopoulos L , Laarman AH , Walker N , McBride BW , |
|
|
Influence of dietary supplementation with Bacillus licheniformis and Saccharomyces cerevisiae as alternatives to monensin on growth performance, antioxidant, immunity, ruminal fermentation and microbial diversity of fattening lambs. ✅
Go to Publication ✅
Scientific reports (Sci Rep ) Vol: 8 Issue 1 Pages: 16712 Pub: 2018 Nov 12 Epub: 2018 Nov 12 Authors Jia P , Cui K , Ma T , Wan F , Wang W , Yang D , Wang Y , Guo B , Zhao L , Diao Q , |
|
|
Effect of Saccharomyces boulardii CNCM I-745 as complementary treatment of Helicobacter pylori infection on gut microbiome. ✅
Go to Publication ✅
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology (Eur J Clin Microbiol Infect Dis ) Vol: 39 Issue 7 Pages: 1365-1372 Pub: 2020 Jul Epub: 2020 Mar 3 Authors Cárdenas PA , Garcés D , Prado-Vivar B , Flores N , Fornasini M , Cohen H , Salvador I , Cargua O , Baldeón ME , |
|
|
Saccharomyces boulardii CNCM I-745 supports regeneration of the intestinal microbiota after diarrheic dysbiosis - a review. ✅
Go to Publication ✅
Clinical and experimental gastroenterology (Clin Exp Gastroenterol ) Vol: 8 Issue Pages: 237-55 Pub: 2015 Epub: 2015 Aug 14 Authors Moré MI , Swidsinski A , |
|
|
Saccharomyces boulardii CNCM I-745 supports regeneration of the intestinal microbiota after diarrheic dysbiosis - a review. ✅
Go to Publication ✅
Clinical and experimental gastroenterology (Clin Exp Gastroenterol ) Vol: 8 Issue Pages: 237-55 Pub: 2015 Epub: 2015 Aug 14 Authors Moré MI , Swidsinski A , |
|
|
Effects of a Saccharomyces cerevisiae fermentation product on fecal characteristics, metabolite concentrations, and microbiota populations of dogs subjected to exercise challenge. ✅
Journal of animal science (J Anim Sci ) Vol: Issue Pages: Pub: 2022 Dec 27 Epub: 2022 Dec 27 Authors Oba PM , Carroll MQ , Sieja KM , Nogueira JPS , Yang X , Epp TY , Warzecha CM , Varney JL , Fowler JW , Coon CN , Swanson KS , |
|
|
Effects of a Saccharomyces cerevisiae fermentation product on fecal characteristics, metabolite concentrations, and microbiota populations of dogs subjected to exercise challenge. ✅
Journal of animal science (J Anim Sci ) Vol: Issue Pages: Pub: 2022 Dec 27 Epub: 2022 Dec 27 Authors Oba PM , Carroll MQ , Sieja KM , Nogueira JPS , Yang X , Epp TY , Warzecha CM , Varney JL , Fowler JW , Coon CN , Swanson KS , |
|
|
Effects of a Saccharomyces cerevisiae fermentation product on fecal characteristics, metabolite concentrations, and microbiota populations of dogs subjected to exercise challenge. ✅
Journal of animal science (J Anim Sci ) Vol: Issue Pages: Pub: 2022 Dec 27 Epub: 2022 Dec 27 Authors Oba PM , Carroll MQ , Sieja KM , Nogueira JPS , Yang X , Epp TY , Warzecha CM , Varney JL , Fowler JW , Coon CN , Swanson KS , |
|
|
Saccharomyces cerevisiae boulardii CNCM I-1079 supplementation in finishing male pigs helps to cope with heat stress through feeding behaviour and gut microbiota modulation. ✅
Go to Publication ✅
The British journal of nutrition (Br J Nutr ) Vol: 127 Issue 3 Pages: 353-368 Pub: 2022 Feb 14 Epub: 2021 May 27 Authors Labussière E , Achard C , Dubois S , Combes S , Castex M , Renaudeau D , |
|
|
Comparison of the Effects of Enzymolysis Seaweed Powder and Saccharomyces boulardii on Intestinal Health and Microbiota Composition in Kittens. ✅
Go to Publication ✅
Metabolites (Metabolites ) Vol: 13 Issue 5 Pages: Pub: 2023 May 8 Epub: 2023 May 8 Authors Zhang M , Mo R , Li M , Qu Y , Wang H , Liu T , Liu P , Wu Y , |
|
|
[Functional biostructure of colonic microbiota (central fermenting area, germinal stock area and separating mucus layer) in healthy subjects and patients with diarrhea treated with Saccharomyces boulardii]. ✅
Go to Publication ✅
Gastroenterologie clinique et biologique (Gastroenterol Clin Biol ) Vol: 34 Suppl 1 Issue Pages: S79-92 Pub: 2010 Sep Epub: Authors Swidsinski A , Loening-Baucke V , Kirsch S , Doerffel Y , |
|
|
Effects of fructooligosaccharides and Saccharomyces boulardii on the compositional structure and metabolism of gut microbiota in students. ✅
Go to Publication ✅
Microbiological research (Microbiol Res ) Vol: 285 Issue Pages: 127741 Pub: 2024 Aug Epub: 2024 May 9 Authors Fu H , Chen Z , Teng W , Du Z , Zhang Y , Ye X , Yu Z , Zhang Y , Pi X , |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
